Transgene-Free Cynomolgus Monkey iPSCs Generated under Chemically Defined Conditions
Non-human primates (NHPs) are pivotal animal models for translating novel cell replacement therapies into clinical applications, including validating the safety and efficacy of induced pluripotent stem cell (iPSC)-derived products. Preclinical development and the testing of cell-based therapies idea...
Main Authors: | Yuliia Tereshchenko, Nesil Esiyok, Enrique Garea-Rodríguez, Daniele Repetto, Rüdiger Behr, Ignacio Rodríguez-Polo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/13/6/558 |
Similar Items
-
Effective and stable gene transduction in rhesus macaque iPSCs capable of T-lineage differentiation utilizing the piggyBac system
by: Masahiro Tanaka, et al.
Published: (2024-12-01) -
MHC-identical and transgenic cynomolgus macaques for preclinical studies
by: Hirohito Ishigaki, et al.
Published: (2018-11-01) -
Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
by: Suman C. Nath, et al.
Published: (2023-11-01) -
Modelling Takenouchi-Kosaki syndrome using disease-specific iPSCs
by: Suganya Thanasegaran, et al.
Published: (2023-12-01) -
Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
by: Guang Yang, et al.
Published: (2018-09-01)